Supportive Care

 Print this Page

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm .

PLEASE NOTE: All links in the table below open PDF documents.

PROTOCOL CODE and DESCRIPTION	AVAILABLE DOCUMENTS (revision date indicated in red)
SCDEXA: Dexamethasone as Treatment for Cerebral Edema or CNS Swelling.	- Protocol (01 May 2009)
SCDRUGRX: Management of Hypersensitivity Reactions to Chemotherapeutic Agents.	- Protocol (01 May 2009)
SCHYPCAL: Guidelines for the diagnosis and management of malignancy related hypercalcemia Hyperlink to PharmaCare http://www.health.gov.bc.ca/pharmacare/sa/criteria/restricted/pamidronate.html	- Protocol (01 May 2009)
SCMESNA: MESNA dosage modification for hematuria secondary to oxazaphosphorines (eg. Ifosfamide and Cyclophosphamide)	- Protocol (01 Dec 2009)
SCNAUSEA: Antiemetic guidelines Hyperlinks to PharmaCare http://www.health.gov.bc.ca/pharmacare/sa/criteria/restricted/ondansetron.html, http://www.health.gov.bc.ca/pharmacare/sa/criteria/restricted/granisetron.html	- Protocol (01 May 2009)
SCPAINLI: Extreme Pain Therapy Using Parenteral Lidocaine	- Protocol (01 May 2009)  - Patient handout (01 Nov 2003)
SCPAINSU: Incident pain therapy using sufentanil via sublingual route	- Protocol (01 May 2009)  - Preprinted Order (01 May 2009)